Business Context and Reporting Period
This Form 8-K Current Report was filed by American Vanguard Corporation on June 19, 2002. The filing discloses a material corporate event under Item 5 (Other Events) regarding an acquisition by a wholly-owned subsidiary.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document serves solely to announce a corporate transaction.
Material Changes
On June 11, 2002, Amvac Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation, acquired the Folex cotton defoliant business conducted in the United States by Aventis CropScience USA. This acquisition occurred prior to Bayer AG's acquisition of Aventis CropScience S.A.
Guidance, Outlook, and Risks
The filing does not contain management guidance, future outlook, risk factors, or contingencies related to the acquisition. It references a press release (Exhibit 99.5) for further details on the transaction.
Investor Verification Checklist
- Verify the purchase price and payment terms of the Folex cotton defoliant business acquisition.
- Review the full text of the June 11, 2002 press release (Exhibit 99.5) for strategic rationale.
- Assess the impact of this acquisition on the company's product portfolio and market share in the agricultural chemicals sector.
- Confirm the regulatory status of the Folex product line post-acquisition.